ABCL Q1 2020 Earnings — AbCellera Biologics Inc. Revenue & Financial Results | Market Cap Arena

ABCLAbCellera Biologics Inc.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+87.8% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$2M-45.6% margin

Net Income

-$2M-44.9% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+45.4%

Cash Flow

Operating Cash Flow

-$764,000

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$10M

Cash & Equivalents

-$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+87.8%
Gross Profit	$5M	$468,009	+895.1%
Operating Income	-$2M	-$712,714	-197.7%
Net Income	-$2M	-$302,883	-591.0%